Search

everythinglearnresearchcommunity

for

Search:↓

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.